Myocardial Infarction Drugs Market Key Players : Astrazeneca plc, Janssen Biotech, Inc., Merck & Co. Inc., Sanofi SA, Pfizer Inc., Bayer AG, Novartis International AG

Myocardial infarction, commonly known as heart attack, occurs due to reduced blood flow to a part of the heart, causing damage to the heart muscle. The medications, which are used to treat heart attacks are known as myocardial infarction drugs. The reduced blood flow further causes blockage in the supply of oxygen to the heart, which is due to atherosclerosis, a process in which the plaque is formed on the inside wall of the coronary vein or one of its minor branches. Myocardial infraction occurs to individuals with risk factors such as diabetes, dyslipidemia, and smoking.

Comprehensive competitive analysis and profiles of major market players, such as Astrazeneca plc, Janssen Biotech, Inc., Merck & Co. Inc., Sanofi SA, Pfizer Inc., Bayer AG, Novartis International AG, Daiichi Sankyo Company Limited, Boehringer Ingelheim GmbH, and Eli Lilly & Company are also provided in this report.

Get Sample PDF Brochure : https://www.alliedmarketresearch.com/request-toc-and-sample/4124

Major factors that drive the market growth are growth in incidences of cardiovascular diseases as well as hypertension, diabetes, and obesity. However, stringent regulatory policies by governing bodies coupled with high cost of clinical trials impede the market growth. Moreover, the advancements in technology and the increase in acceptance of newer treatment technologies create lucrative opportunities for key market players especially in untapped economies.

The global myocardial infarction market is segmented based on product type, distribution channel, and region. Based on product, the market is divided into analgesics (morphine sulfate), antiplatelet agents (aspirin, vorapaxar, and clopidogre), vasodilators (nitroglycerin), thrombolytics (tenecteplase and alteplase [t-PA]), anti-thrombotic agents (heparin, bivalirudin, and enoxaparin. Glycoprotein IIb/IIIa inhibitors abciximab, tirofiban, and eptifibatide), glycoprotein IIb/IIIa inhibitors, B adrenergic blockers (metoprolol and esmolol), angiotensin receptor blockers (candesartan and valsartan), and angiotensin converting enzyme inhibitors (enalapril, captopril, and lisinopril). By distribution channel, the market is classified into hospital pharmacies, hospitals, drug stores, and online drug stores. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

• This report provides an extensive analysis of the current and emerging trends and dynamics in the global myocardial infarction market.
• In-depth analysis is done by constructing market estimations for the key market segments between 2016 and 2023 to identify the prevailing market opportunities.
• This study evaluates the competitive landscape and value chain to understand the competitive environment across the geographies.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Comprehensive analysis of all regions is provided to determine the prevailing opportunities in these geographies.
Myocardial Infarction Drugs Market Key Segments:

By Product Type

• Analgesics

o Morphine sulfate

• Antiplatelet Agents

o Aspirin
o Vorapaxar
o Clopidogre

• Vasodilators

o Nitroglycerin

• Thrombolytics
o Tenecteplase
o Alteplase (t-PA)

• Anti-Thrombotic Agents

o Heparin
o Bivalirudin
o Enoxaparin

• Glycoprotein IIb/IIIa Inhibitors

o Abciximab
o Tirofiban
o Eptifibatide

• Adrenergic Blockers

o Metoprolol
o Esmolol

• Angiotensin Receptor Blockers

o Candesartan
o Valsartan

• Angiotensin Converting Enzyme Inhibitors

o Enalapril
o Captopril
o Lisinopril

By Distribution Channel

• Hospital Pharmacies
• Hospitals
• Drug Stores
• Online Drug Stores

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.